Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 10:04AM ET
9.81
Dollar change
+0.03
Percentage change
0.31
%
IndexRUT P/E- EPS (ttm)-17.57 Insider Own74.63% Shs Outstand85.77M Perf Week-14.77%
Market Cap841.91M Forward P/E- EPS next Y- Insider Trans-0.01% Shs Float21.77M Perf Month-32.25%
Income-44.24M PEG- EPS next Q- Inst Own1.88% Short Float2.52% Perf Quarter-30.23%
Sales0.00M P/S- EPS this Y- Inst Trans27.51% Short Ratio7.27 Perf Half Y-11.14%
Book/sh0.74 P/B13.32 EPS next Y- ROA-215.90% Short Interest0.55M Perf Year-54.03%
Cash/sh0.29 P/C33.56 EPS next 5Y- ROE-269.01% 52W Range8.26 - 30.40 Perf YTD-61.81%
Dividend Est.- P/FCF- EPS past 5Y48.82% ROI-68.83% 52W High-67.73% Beta1.94
Dividend TTM- Quick Ratio3.29 Sales past 5Y227.98% Gross Margin- 52W Low18.77% ATR (14)1.09
Dividend Ex-DateJan 13, 2023 Current Ratio3.72 EPS Y/Y TTM-411.67% Oper. Margin- RSI (14)36.21 Volatility10.78% 10.26%
Employees4 Debt/Eq0.03 Sales Y/Y TTM-100.00% Profit Margin- Recom2.00 Target Price45.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q101.34% Payout- Rel Volume5.17 Prev Close9.78
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 13 BMO Avg Volume75.61K Price9.81
SMA20-14.18% SMA50-25.14% SMA200-28.59% Trades Volume51,903 Change0.31%
Date Action Analyst Rating Change Price Target Change
Apr-29-21Resumed Stephens Overweight $18 → $19
Feb-10-21Initiated Piper Sandler Overweight $15
May-21-20Initiated Raymond James Outperform $20
Jan-04-19Initiated Oppenheimer Outperform $24
Feb-12-18Reiterated B. Riley FBR, Inc. Buy $19 → $49
Feb-09-18Reiterated Chardan Capital Markets Buy $37.50 → $75
Feb-09-18Reiterated Chardan Capital Markets Buy $10 → $75
Dec-08-17Initiated B. Riley FBR, Inc. Buy $19
Jun-12-17Initiated Chardan Capital Markets Buy $10
Jun-06-17Initiated Ladenburg Thalmann Buy $11
Nov-13-24 06:00AM
Oct-22-24 04:05PM
Oct-01-24 04:05PM
Sep-04-24 04:05PM
Aug-13-24 06:00AM
07:00AM Loading…
Aug-09-24 07:00AM
Aug-08-24 04:05PM
Jul-02-24 04:05PM
Jun-18-24 04:05PM
May-30-24 04:05PM
May-28-24 04:05PM
May-09-24 04:10PM
Mar-28-24 05:32AM
Mar-26-24 06:32AM
06:00AM
07:00AM Loading…
Mar-21-24 07:00AM
Dec-15-23 09:04AM
Nov-13-23 07:00AM
Oct-30-23 12:00PM
Aug-23-23 12:36PM
Apr-03-23 09:01AM
Mar-29-23 10:13AM
Feb-28-23 08:00AM
Dec-27-22 07:00AM
Nov-16-22 05:05AM
Sep-19-22 09:43AM
Sep-01-22 04:05PM
Aug-25-22 08:00AM
Aug-23-22 07:11AM
Aug-19-22 08:00AM
04:05PM Loading…
Aug-15-22 04:05PM
Aug-11-22 06:00AM
Aug-10-22 12:46PM
Aug-03-22 08:00AM
Aug-01-22 08:30AM
07:30AM
Jul-22-22 12:21PM
Jul-19-22 08:00AM
Jul-14-22 09:40AM
Jul-06-22 08:00AM
Jun-29-22 08:00AM
Jun-28-22 09:40AM
May-26-22 11:03AM
May-23-22 09:57AM
08:30AM
May-09-22 08:30AM
Apr-08-22 09:57AM
Mar-31-22 08:00AM
Mar-15-22 05:00PM
Feb-17-22 08:00AM
Feb-03-22 05:38PM
Jan-25-22 08:00AM
Jan-12-22 12:00PM
Dec-20-21 07:51PM
Dec-11-21 11:59AM
Nov-22-21 08:00AM
Nov-12-21 09:54AM
09:24AM
07:00AM
Oct-29-21 08:00AM
Oct-28-21 03:05PM
Oct-13-21 04:05PM
Sep-28-21 04:01PM
Sep-24-21 08:00AM
Sep-17-21 07:06AM
Sep-15-21 08:00AM
Sep-09-21 08:00AM
Sep-08-21 08:00AM
Aug-05-21 10:55AM
08:00AM
Jul-29-21 03:05PM
Jul-22-21 08:00AM
Jul-19-21 04:01PM
02:09AM
Jul-14-21 08:00AM
Jul-06-21 08:00AM
Jul-01-21 08:00AM
Jun-28-21 08:45AM
08:00AM
Jun-21-21 06:00AM
Jun-10-21 08:00AM
May-20-21 02:57AM
May-18-21 08:00AM
May-13-21 08:00AM
May-06-21 12:19PM
09:23AM
09:15AM
08:00AM
May-05-21 12:29PM
08:00AM
Apr-28-21 08:00AM
Apr-21-21 11:43AM
Apr-19-21 08:00AM
Apr-12-21 08:00AM
Apr-07-21 04:05PM
Mar-21-21 04:20AM
Mar-04-21 08:00AM
Feb-18-21 08:00AM
Feb-11-21 04:01PM
Feb-10-21 10:05AM
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
USMAN NASSIMDirectorJun 28 '24Option Exercise6.933,45223,9225,088Jul 01 06:00 PM
USMAN NASSIMDirectorJun 28 '24Sale12.003,45241,4381,636Jul 01 06:00 PM
USMAN NASSIMDirectorMay 01 '24Option Exercise6.9320,000138,60021,636May 02 06:19 PM
USMAN NASSIMDirectorMay 01 '24Sale14.1320,000282,5771,636May 02 06:19 PM
USMAN NASSIMDirectorApr 01 '24Option Exercise6.9320,000138,60021,636Apr 03 04:01 PM
USMAN NASSIMDirectorApr 01 '24Sale16.1520,000323,0001,636Apr 03 04:01 PM
USMAN NASSIMDirectorMar 15 '24Option Exercise6.9320,000138,60021,636Mar 19 04:47 PM
USMAN NASSIMDirectorMar 15 '24Sale17.2620,000345,2001,636Mar 19 04:47 PM